Virtual Medicinal Product (VMP) - Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Lamivudine 300mg / Tenofovir disoproxil 245mg / Doravirine 100mg tablets | Start Date 18-03-2019 | End Date |
| Abbreviated Name | Abbreviated Name Lamivudine 300mg/Tenofovir disoproxil 245mg/Doravirine 100mg | Start Date 18-03-2019 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- J05AR24
- BNF Codes
-
- BNF code 05030100
| Code | Start Date | End Date |
|---|---|---|
| 36903911000001101 | 18-03-2019 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Doravirine | Based on Ingredient Substance | 100 mg | ||
| Lamivudine | Based on Ingredient Substance | 300 mg | ||
| Tenofovir disoproxil | Based on Ingredient Substance | 245 mg |
Name
Lamivudine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
300
Strength and UOM (Dmr)
Name
Doravirine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
Name
Tenofovir disoproxil
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
245
Strength and UOM (Dmr)
Parent Products
-
VTMLamivudine + Tenofovir disoproxil + Doravirine
-
VMP(Current) Lamivudine 300mg / Tenofovir disopro...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet |